RxDoctor Payments Data

Donald Ours, DO

Family Medicine · South Point, OHNPI 1255786653

Payments from drug & device makers

$296in general payments, 2019–2025

Across 21 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$73
  • Pfizer$65
  • AstraZeneca$64
  • Lilly USA, LLC$38
  • AbbVie$26
  • Dexcom, Inc.$18
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk4$73
Pfizer5$65
AstraZeneca5$64
Lilly USA, LLC3$38
AbbVie2$26
Dexcom, Inc.1$18
GSK1$12

How this compares

$296 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$23,682
Medicare patients
137
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide22$22,659
OzempicSemaglutide20$21,864
EliquisApixaban16$18,269
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,237
JardianceEmpagliflozin14$9,902
FarxigaDapagliflozin Propanediol11$6,299
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,725
ShingrixVaricella-Zoster Ge/As01b/Pf13$2,848
Atorvastatin Calcium179$1,562
Albuterol Sulfate HfaAlbuterol Sulfate46$1,512
Boostrix TdapDiphth,pertuss(Acell),tet Vac16$1,112
Ventolin HfaAlbuterol Sulfate20$1,078
Omeprazole90$970
Duloxetine Hcl37$950
Pantoprazole Sodium58$907

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$38$22,65922 claims
Novo NordiskOzempic$73$21,86420 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix$12$19,81043 claims
PfizerEliquis$65$18,26916 claims
AstraZenecaFarxiga$64$6,29911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in South Point

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →